C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2002
10/29/2002	US6472509 Feline cytokine protein
10/29/2002	US6472211 Amplification of transcription of preferential genes; obtain cell, incubate with regulatory protein, monitor propagation of cells
10/29/2002	US6472196 Amino acid sequence of L-phenylalanine ammonia-lyase
10/29/2002	US6472183 Immunity against Actinobacillus pleuropneumoniae's RTX toxins APX
10/29/2002	US6472182 Culturing a microorganism selected from of micrococcus luteus, clostridium acetobutylicum, candida versatilis, rhizopus species and monascus purpureus in a medium to prodce transglutaminase in the medium or in the cell
10/29/2002	US6472181 Hybrid matrix implants and explants
10/29/2002	US6472179 Nucleotide sequences coding fusion protein for use in the treatment of osteoporosis, cancers, and cachexia
10/29/2002	US6472176 Polynucleotide encoding chimeric protein and related vector, cell, and method of expression thereof
10/29/2002	US6472175 Using a baculovirus expression system, such that the recombinant nucleic acid being expressed in baculovirus expression system codes for a protein with n-linked glycosylation
10/29/2002	US6472174 Polypeptides bind to the hek or elk receptor, the nucleic acids encoding such polypeptides; genetic engineering
10/29/2002	US6472172 DNA encoding a novel human inhibitor-of-apoptosis protein
10/29/2002	US6472143 Determining the amount of the complex in a sample and correlating the amount to the presence or absence of a tumor
10/29/2002	US6471964 Designated as structural protein-1 (sp-1), the isolated sp-1 protein, and use of the nucleic acid and/or protein for diagnostic or vaccine purposes
10/29/2002	US6471500 Using a mammalian cell culture medium completely free of nonrecombinant mammalian proteins which are not derived from the host cells.
10/29/2002	EP1144613A4 Methods for making proteins containing free cysteine residues
10/29/2002	EP0960196A4 Novel receptor that causes cell death
10/29/2002	CA2212747C Mhc-antigen complexes for detecting and purifying antigen-specific t cells
10/29/2002	CA2173102C Dna sequence coding for a bmp receptor
10/29/2002	CA2101325C Cell-free and whole cell ice nucleators and process for their production
10/29/2002	CA2090515C Anti-feline calicivirus recombinant antibody and gene fragment encoding the same
10/29/2002	CA2063431C Receptors for fibroblast growth factors
10/29/2002	CA2046016C Hiv monoclonal antibody
10/29/2002	CA2045552C Cancer related haptoglobin
10/24/2002	WO2002084294A2 Gastrointestinal glutathione peroxidase in hepatitis c virus infections
10/24/2002	WO2002083937A2 Methods using o6-alkylguanine-dna alkyltransferases
10/24/2002	WO2002083899A1 Cancer-associated genes
10/24/2002	WO2002083898A1 Full-length human cdnas encoding potentially secreted proteins
10/24/2002	WO2002083890A2 Use of clya hemolysin for excretion of fusion proteins
10/24/2002	WO2002083874A2 Endothelial cell expression patterns
10/24/2002	WO2002083873A2 Enzymes
10/24/2002	WO2002083866A2 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
10/24/2002	WO2002083859A2 Surface proteins of streptococcus pyogenes
10/24/2002	WO2002083858A2 Methods to inhibit viral replication
10/24/2002	WO2002083855A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
10/24/2002	WO2002083853A2 Method for enhancing the translation and expression of recombinant proteins
10/24/2002	WO2002083840A2 Compositions and methods for transepithelial transport of membrane-bounded vesicles and virions
10/24/2002	WO2002083736A2 G-protein coupled receptor molecules and uses thereof
10/24/2002	WO2002083735A1 Novel receptor protein and dna thereof
10/24/2002	WO2002083733A2 Polynucleotides and polypeptides of the ifnalpha-6 gene
10/24/2002	WO2002083721A1 Protein cluster v
10/24/2002	WO2002083712A2 Transporters and ion channels
10/24/2002	WO2002083711A2 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
10/24/2002	WO2002083709A2 Kinases and phosphatases
10/24/2002	WO2002083704A1 Vascular endothelial growth factor 2
10/24/2002	WO2002083069A2 Recombinant proteins of orientia tsutsugamushi
10/24/2002	WO2002083067A2 Prodrugs via acylation with cinnamate
10/24/2002	WO2002060931A3 A fimbria-like gene in bifidobacteria
10/24/2002	WO2002057226A9 68730 and 69112 protein kinase molecules and uses therefor
10/24/2002	WO2002045524A3 Prolyl endoprotease from aspergillus niger
10/24/2002	WO2002000913A9 MODULATION OF β-AMYLOID LEVELS BY β-SECRETASE BACE2
10/24/2002	WO2001062793A9 Estrogen receptor beta variants and methods of detection thereof
10/24/2002	WO2001059075A9 Improved sialylation of glycoproteins
10/24/2002	WO2001055337A3 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
10/24/2002	WO2001055298A8 Use of a nucleotide sequence for enhancing protein synthesis and expression of proteins
10/24/2002	WO1999050288A3 Mammalian blood loss-induced gene, kd312
10/24/2002	US20020157127 Transgene that comprises DNA encoding for epitope tagged TATA box binding protein (TBP), production of transgenic animals which express epitope-tagged TBP and use of epitope tagged TBP for isolating and affinity purifying transcription factors
10/24/2002	US20020156266 Sodium phosphate cotransporter expressed on apical surface of intestinal epithelial cells (huNpt2B) and polypeptides related thereto
10/24/2002	US20020156258 Transcription factor of MHC class II genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
10/24/2002	US20020156252 Novel Stra6 polypeptides
10/24/2002	US20020156248 Novel method for targeted delivery of nucleic acids
10/24/2002	US20020156244 Adipocyte complement related protein zacrp13
10/24/2002	US20020156243 Adipocyte-specific protein homologs
10/24/2002	US20020156234 Obtaining insulin precursors; generate suspension of insulin and cysteine hydrochloride, heat, recover insulin precursors
10/24/2002	US20020156013 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
10/24/2002	US20020156007 Apolipoprotein analogues
10/24/2002	US20020156006 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/24/2002	US20020156004 Polypeptides having significant homology to the prolactin receptor protein
10/24/2002	US20020156001 Novel fibroblast growth factor ( FGF23) and methods for use
10/24/2002	US20020155998 Erythropoietin analog-human serum albumin fusion
10/24/2002	US20020155987 Isolated endostatin, especially approximately 20 kDa and corresponds to a C-terminal fragment of collagen type XVIII
10/24/2002	US20020155605 Expression vector for use as tool in controlling gene expression in plants
10/24/2002	US20020155577 Compound for use in the treatment of parkinson's disease
10/24/2002	US20020155562 Glutathionylspermidine synthetase and processes for recovery and use thereof
10/24/2002	US20020155556 Geenrting target particles in genetically engineered cells; obtain genetically engineered cells containing expression vector coding prefrential gene, express vector recover gene product
10/24/2002	US20020155547 Polypeptide for use in the treatment of cancer, hepatitis, multiple sclerosis, fibrosis, inflammatory or autoimmune diseases, cancers and viral diseases
10/24/2002	US20020155546 Adipocyte complement related protein ZACRP12
10/24/2002	US20020155545 Chemokines expressed in pancreas
10/24/2002	US20020155543 Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disorders
10/24/2002	US20020155541 Method and system for providing real-time, in situ biomanufacturing process monitoring and control in response to IR spectroscopy
10/24/2002	US20020155539 Calcium channel polynucleotides, polypeptides, and antibodies
10/24/2002	US20020155537 Method for making heteromultimeric polypeptides
10/24/2002	US20020155536 Expression cloning in filamentous fungi
10/24/2002	US20020155532 Method of producing biologically active human acidic fibroblast growth factor and its use in promotiong angiogenesis
10/24/2002	US20020155531 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
10/24/2002	US20020155529 Viral vectors having reduced virulence
10/24/2002	US20020155528 Regulation of human CysLT2-like GPCR protein
10/24/2002	US20020155527 Nucleotide sequences coding membrane protein for use in the treatment of tumors
10/24/2002	US20020155525 Expression vector for use in generation of preferential polypeptides in culture
10/24/2002	US20020155519 Human blood bacterium
10/24/2002	US20020155510 Dendritic cell-specific antibodies
10/24/2002	US20020155500 Detecting modulators of receptor binding activity; obtain sample containing receptor protein, incubate with modulator, monitor and evaluate protein binding
10/24/2002	US20020155498 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
10/24/2002	US20020155453 Method for generating diversity
10/24/2002	US20020155452 Fusion of jAZF1 and jjAZ1 genes in endometrial stromal tumors
10/24/2002	US20020155447 Nucleotide sequences coding polypeptide for use in the treatment of cancer
10/24/2002	US20020155441 Polypeptides for use in the, detection, prevention, treatment and diagnosis of malarial infection
10/24/2002	US20020155434 Fusion protein for use in the treatment of viral diseases
10/24/2002	US20020155433 Polypeptide for use the prevention of infections associated with tissue grafting
10/24/2002	US20020155428 Retrovirus from the HIV group and its use
10/24/2002	US20020155122 Immunologically significant herpes simplex virus antigens and methods for identifying and using same

1 ... 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 ... 1125